BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12721191)

  • 1. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding.
    Hickey M; Pillai G; Higham JM; Sullivan M; Horncastle D; Doherty D; Stamp G
    Hum Reprod; 2003 May; 18(5):1100-6. PubMed ID: 12721191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial expression of steroid receptors in postmenopausal hormone replacement therapy users: relationship to bleeding patterns.
    Vani S; Critchley HO; Fraser IS; Hickey M
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):27-34. PubMed ID: 18201403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
    Rogers PA; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
    Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
    Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant.
    Palmer JA; Lau TM; Hickey M; Simbah M; Rogers PA
    Hum Reprod; 1996 Oct; 11(10):2142-50. PubMed ID: 8943519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular density in conditions of endometrial atrophy.
    Hickey M; Lau TM; Russell P; Fraser IS; Rogers PA
    Hum Reprod; 1996 Sep; 11(9):2009-13. PubMed ID: 8921081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels.
    Hickey M; Doherty DA; Fraser IS; Sloboda DM; Salamonsen LA
    Hum Reprod; 2008 Apr; 23(4):912-8. PubMed ID: 18216041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial vasculature in Norplant users.
    Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M; Fraser I; Dwarte D; Graham S
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
    Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbances of endometrial bleeding with hormone replacement therapy.
    Thomas AM; Hickey M; Fraser IS
    Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of estrogen/progestogen receptors in the endometrium.
    Casper RF
    Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM; Rogers PA; Affandi B
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
    Hickey M; Fraser IS
    Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding with menopausal hormone therapy.
    Hickey M; Agarwal S
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):141-9. PubMed ID: 18977184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?
    Hickey M; Crewe J; Goodridge JP; Witt CS; Fraser IS; Doherty D; Christiansen FT; Salamonsen LA
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5528-35. PubMed ID: 16046584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors of MMPs.
    Hickey M; Higham J; Sullivan M; Miles L; Fraser IS
    Fertil Steril; 2001 Feb; 75(2):288-96. PubMed ID: 11172829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal vaginal bleeding in women using hormone replacement therapy.
    Burbos N; Musonda P; Duncan TJ; Crocker SG; Nieto JJ; Morris EP
    Menopause Int; 2012 Mar; 18(1):5-9. PubMed ID: 22323674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the measurement of placental protein-14 and CA-125 in plasma and uterine flushings useful in the evaluation of peri-menopausal and post-menopausal bleeding?
    Li TC; Okon MA; Dalton CF; Heatley M; Laird SM
    Hum Reprod; 1998 Oct; 13(1O):2895-901. PubMed ID: 9804252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.